fludarabinfosfat ''ebewe'' 25 mg/ml koncentrat za raztopino za injiciranje ali infundiranje
ebewe pharma - fludarabin - koncentrat za raztopino za injiciranje/infundiranje - fludarabin 19,75 mg / 1 ml - fludarabin
kalcijev folinat sandoz 10 mg/ml raztopina za injiciranje/infundiranje
sandoz gmbh - folinska kislina - raztopina za injiciranje/infundiranje - folinska kislina 10 mg / 1 ml - kalcijev folinat
novantrone 2 mg/ml koncentrat za raztopino za injiciranje/infundiranje
meda pharma gmbh & co. kg - mitoksantron - koncentrat za raztopino za injiciranje/infundiranje - mitoksantron 20 mg / 1 ml - mitoksantron
fludarabin actavis 25 mg/ml koncentrat za raztopino za injiciranje/infundiranje
actavis group ptc ehf. - fludarabin - koncentrat za raztopino za injiciranje/infundiranje - fludarabin 19,75 mg / 1 ml - fludarabin
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
dacogen
janssen-cilag international n.v. - decitabin - leukemija, myeloid - antineoplastična sredstva - zdravljenje odraslih bolnikov z novo diagnosticirano de novo ali sekundarno akutno mieloično levkemijo (aml), v skladu s klasifikacijo svetovne zdravstvene organizacije (who), ki niso kandidati za standardno indukcijsko kemoterapijo.
spectrila
medac gesellschaft fuer klinische spezialpraeparate mbh - asparaginaza - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - spectrila je naveden kot sestavni del antineoplastic kombinirano zdravljenje za zdravljenje akutno limfoblastno levkemijo, (vse), pri pediatričnih bolnikih od rojstva do 18 let in odrasli.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
fludara 10 mg filmsko obložene tablete
genzyme europe b.v. - fludarabin - filmsko obložena tableta - fludarabin 7,9 mg / 1 tableta - fludarabin
fludara 10 mg filmsko obložene tablete
genzyme europe b.v. - fludarabin - filmsko obložena tableta - fludarabin 7,9 mg / 1 tableta - fludarabin